Skip to content
Seoul Market Wire

Korean stocks, the won and the economy

  • KOSPI5,067.44+1.99%
  • KOSDAQ662.81+1.96%
  • USD/KRW1,333.0-0.19%
  • Samsung Elec.194,700+2.31%
  • SK hynix1,144,000+4.19%

KRX close & FX ref. 2026-11-18 (KST)

Stocks

Six of eight brokers reviewed cut PharmaResearch targets

Targets in the eight-report comparison range from 324,000 to 530,000 won. Export growth supported revenue, but a larger cosmetics contribution and CG USA expenses constrained profit.

Large container cargo ship sailing across open water on an export route.
Large container cargo ship sailing across open water on an export route. Illustration: Seoul Market Wire

Market data: Korea Exchange regular-session close & Hana Bank USD/KRW reference rate, 2026-11-16 (KST)

Market data chart for Six of eight brokers reviewed cut PharmaResearch targets

Sources

  1. PharmaResearch — Preliminary third-quarter 2026 results pharmaresearch.com
  2. Yuanta Securities Korea — PharmaResearch: Exports lead growth as margins take a breather (2026-11-09) stock.naver.com
  3. IBK Securities — PharmaResearch: Time to focus on export-led growth (2026-11-09) stock.naver.com
  4. Eugene Investment & Securities — PharmaResearch 3Q26 review: Focus on profit growth over margins (2026-11-09) stock.naver.com
  5. Eugene Investment & Securities — Full PharmaResearch report (2026-11-09) consensus.hankyung.com
8 more sources
  1. Daishin Securities — PharmaResearch: The share-price bottom has passed (2026-11-09) stock.naver.com
  2. Kiwoom Securities — PharmaResearch: The CEO's philosophy comes into view (2026-11-09) stock.naver.com
  3. Kyobo Securities — PharmaResearch 3Q26 review (2026-11-09) stock.naver.com
  4. Mirae Asset Securities — PharmaResearch 3Q26 review (2026-11-09) stock.naver.com
  5. Shinhan Securities — PharmaResearch: Growth evident despite concerns (2026-11-09) stock.naver.com
  6. IBK Securities — PharmaResearch previous target (2026-08-10) stock.naver.com
  7. Yuanta Securities Korea — PharmaResearch previous target (2026-08-10) stock.naver.com
  8. Kiwoom Securities — PharmaResearch previous target (2026-10-28) stock.naver.com